Arabic Behçet’s Disease Quality of Life Questionnaire

📜
Abstract

Health-Related Quality of Life assessments are critical tools in modern Rheumatology, offering insights into the patient experience that objective clinical markers often miss. The Behçet's Disease Quality of life Questionnaire (BD-QoL) was originally developed in the United Kingdom to capture the unique, multifaceted impacts of this rare systemic inflammatory disorder. Because Behçet's disease can cause a wide array of distressing symptoms—ranging from painful mucosal ulcers to severe ocular and neurological complications—generic health surveys frequently fail to capture the specific daily burdens these patients face.

To bridge the gap in cross-cultural psychometric tools, researchers undertook a rigorous translation and adaptation process to create an Arabic version of the BD-QoL. This adaptation ensures that Arabic-speaking populations can be accurately assessed using a culturally equivalent instrument. The availability of this localized tool is essential for both clinical monitoring and international research, allowing clinicians to quantify the subjective burden of the disease and evaluate the efficacy of therapeutic interventions in a standardized manner.

📊 Psychometric Scorecard

Items Count
30
Structure
Unidimensional
Cronbach's α
0.89
Validation Country
📍 Lebanon

Translation Method: Forward and backward translation with expert committee review

Authors

🏛 American University of Beirut Medical Center

🏛 American University of Beirut

🏛 American University of Beirut

🏛 American University of Beirut Medical Center

🏛 American University of Beirut Medical Center

🏛 American University of Beirut Medical Center

🏛 American University of Beirut Medical Center

🏛 American University of Beirut Medical Center

🏛 American University of Beirut Medical Center

👤 Abla Sibai
🏛 American University of Beirut

Purpose

The primary objective of adapting the BD-QoL into Arabic is to provide clinicians and researchers with a disease-specific metric that accurately reflects the lived experience of Arabic-speaking patients with Behçet's disease. While generic Quality of life instruments are widely used in Rheumatology, they often lack the sensitivity required to detect nuanced clinical changes in conditions with highly specific symptom profiles. By utilizing a targeted tool, healthcare providers can better understand how unique manifestations, such as oral ulcers or visual impairments, interfere with daily functioning and emotional well-being.

Furthermore, establishing a psychometrically sound Arabic version facilitates cross-cultural comparative research. It allows for the inclusion of Middle Eastern populations in global clinical trials, ensuring that outcome measures are not confounded by language barriers or cultural misunderstandings. This ultimately supports more personalized and effective patient care strategies.

Construct

The psychological and functional construct measured by the BD-QoL is disease-specific Health-Related Quality of Life (HRQoL). In the context of Behçet's disease, HRQoL encompasses the physical limitations, emotional distress, and social participation restrictions directly resulting from the illness. Unlike objective indices of disease severity, which tally the presence of physical lesions or organ involvement, this construct captures the subjective appraisal of how these symptoms disrupt the individual's life trajectory.

The Arabic adaptation of the scale operates on a unidimensional framework, meaning that all items contribute to a single, overarching latent trait of disease-related life quality. The items span various domains of daily living, including mobility challenges, psychological worries about the future, self-esteem issues related to physical appearance, and the perceived burden placed on interpersonal relationships.

Validity

To establish the construct validity of the Arabic BD-QoL, researchers examined its relationship with established measures of functional impairment and clinical severity. Convergent validity was demonstrated through a moderate, positive correlation with a standardized clinical severity score (r = 0.40). This magnitude of association is theoretically expected in rheumatological research, as subjective Quality of life and objective disease activity are related but distinct constructs; patients may develop coping mechanisms that buffer their Quality of life even when disease severity is high.

Additionally, the scale's external validity was supported by its associations with functional independence metrics. The Arabic BD-QoL correlated significantly with the Instrumental Activities of Daily Living (IADL) scale, indicating that higher disease-specific burden aligns with greater difficulties in managing complex daily tasks. The rigorous multi-stage translation process, which included bilingual expert committees and patient pre-testing, further ensured robust content and face validity across cultural boundaries.

Convergent & Discriminant Validation Correlations

Reference Instrument Correlation Coefficient (r)
Clinical Severity Score r=0.40
Lawton Instrumental Activities of Daily Living (IADL) Positive correlation

Reliability

The psychometric evaluation of the Arabic BD-QoL revealed excellent reliability metrics, indicating that the tool measures the underlying construct with high precision and consistency. Because the scale utilizes a dichotomous response format, internal consistency was evaluated using the Kuder-Richardson Formula 20 (KR-20), yielding a strong coefficient of 0.89. This value comfortably exceeds the standard threshold of 0.70 recommended for research and clinical instruments, confirming that the 30 items are highly interrelated and reliably capture the same overarching Quality of life construct.

Temporal stability was also rigorously assessed to ensure the scale's utility in longitudinal monitoring. Test-retest reliability, evaluated via Spearman's rank correlation coefficient, was exceptionally high at 0.91. This demonstrates that patient scores remain stable over short periods when their clinical status has not changed, making the Arabic BD-QoL a dependable tool for tracking disease progression or evaluating the efficacy of therapeutic interventions over time.

Factor Analysis

The dimensionality of the Arabic BD-QoL was investigated using Exploratory Factor Analysis (EFA). The analytical objective was to determine whether the translated items clustered into distinct sub-domains or loaded onto a single primary factor. The results of the EFA indicated a convergence of all 30 items, strongly supporting a unidimensional structure for the adapted scale. This aligns with the theoretical conceptualization of the instrument as a holistic measure of disease-specific Quality of life.

It is important to note, however, that the factor analysis was conducted on a relatively small sample size of 41 patients. In psychometric literature, EFA typically requires larger subject-to-variable ratios to ensure the stability of factor loadings. While the unidimensional finding is consistent with the original English version of the scale, researchers acknowledge this sample size limitation and recommend that future studies with larger, multi-center cohorts conduct Confirmatory Factor Analysis (CFA) to further validate the structural integrity of the Arabic instrument.

Instrument

Test Type Self-report questionnaire
Format 30 items, dichotomous response format (True/False)
Scoring Items are scored 1 for True and 0 for False. Total scores range from 0 to 30, with higher scores indicating poorer Quality of life.
Language Arabic
Population Medical patients, Adults
Age Group 18 and older
Administration Self-administered
Completion Time Less than 10 minutes

Scoring & Interpretation Guidelines

Scoring Instructions True = 1, False = 0. Total score is the sum of all items.
Normative Reference Values Mean = 9.12 (SD = 6.69)

Arabic Behçet's Disease Quality of Life Questionnaire Items

📋 Items are currently not available

The individual items of this scale are not publicly available. Researchers interested in using this instrument should contact the original authors directly to request the scale materials.

Sample

The study sample consisted of 41 consecutive Lebanese patients diagnosed with Behçet's disease attending Rheumatology clinics at the American University of Beirut Medical Center. The sample included 24 males and 17 females, with a mean age of 34 years (SD = 11).

Permissions & Test Year

Permission to use and adapt the scale was granted by the developers of the original Leeds BD-QoL questionnaire.

Test Year: 2011

📚
References
26 references
  1. Arayssi T, Hamdan A: New insights into the pathogenesis and therapy of Behcet's disease. Curr Opin Pharmacol. 2004, 4: 183-188. 10.1016/j.coph.2003.10.009. 🔗 https://doi.org/10.1016/j.coph.2003.10.009
  2. Akman A, Sallakci N, Coskun M, Bacanli A, Yavuzer U, Alpsoy E, Yegin O: TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br J Dermatol. 2006, 155: 350-356. 10.1111/j.1365-2133.2006.07348.x. 🔗 https://doi.org/10.1111/j.1365-2133.2006.07348.x
  3. Touma Z, Farra C, Hamdan A, Shamseddeen W, Uthman I, Hourani H, Arayssi T: TNF polymorphisms in patients with Behçet Disease: a meta-analysis. Arch Med Res. 2010, 41: 142-146. 10.1016/j.arcmed.2010.02.002. 🔗 https://doi.org/10.1016/j.arcmed.2010.02.002
  4. Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med. 1999, 341: 1284-1291. 10.1056/NEJM199910213411707. 🔗 https://doi.org/10.1056/NEJM199910213411707
  5. Gilworth G, Chamberlain MA, Bhakta B, Haskard D, Silman A, Tennant A: Development of the BD-QoL: a Quality of life measure specific to Behcet's disease. J Rheumatol. 2004, 31: 931-937.
  6. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P: Endpoints: consensus recommendations from OMERACT IV. Outcome measures in Rheumatology. Lupus. 2000, 9: 322-327. 10.1191/096120300678828424. 🔗 https://doi.org/10.1191/096120300678828424
  7. Hunt SM, McEwen J, McKenna SP: Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985, 35: 185-188.
  8. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002. 🔗 https://doi.org/10.1097/00005650-199206000-00002
  9. Moses AN, Fisher M, Yazici Y: Behcet's syndrome patients have high levels of functional disability, fatigue and pain as measured by a Multi-dimensional Health Assessment Questionnaire (MDHAQ). Clin Exp Rheumatol. 2008, 26: S110-113.
  10. Ertam I, Kitapcioglu G, Aksu K, Keser G, Ozaksar A, Elbi H, Unal I, Alper S: Quality of life and its relation with disease severity in Behcet's disease. Clin Exp Rheumatol. 2009, 27: S18-22.
  11. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum. 1980, 23: 137-145. 10.1002/art.1780230202. 🔗 https://doi.org/10.1002/art.1780230202
  12. Testa MA, Simonson DC: Assesment of quality-of-life outcomes. New Engl J Med. 1996, 334: 835-40. 10.1056/NEJM199603283341306. 🔗 https://doi.org/10.1056/NEJM199603283341306
  13. Yi SW, Kim JH, Lim KY, Bang D, Lee S, Lee ES: The Behcet's disease Quality of life: reliability and validity of the Korean version. Yonsei Med J. 2008, 49: 698-704. 10.3349/ymj.2008.49.5.698. 🔗 https://doi.org/10.3349/ymj.2008.49.5.698
  14. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's disease. Lancet. 1990, 335: 1078-1080. 🔗 https://doi.org/10.1016/0140-6736(90)92643-V
  15. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The Index of ADL: a Standardized Measure of Biological and Psychosocial Function. JAMA. 1963, 185: 914-919. 🔗 https://doi.org/10.1001/jama.1963.03060120024016
  16. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969, 9: 179-186. 🔗 https://doi.org/10.1093/geront/9.3_Part_1.179
  17. Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T: Behcet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol. 2006, 25: 364-367. 10.1007/s10067-005-0058-4. 🔗 https://doi.org/10.1007/s10067-005-0058-4
  18. Krause I, Mader R, Sulkes J, Paul M, Uziel Y, Adawi M, Weinberger A: Behcet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol. 2001, 28: 1033-1036.
  19. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of Health-Related Quality of Life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993, 46: 1417-1432. 10.1016/0895-4356(93)90142-N. 🔗 https://doi.org/10.1016/0895-4356(93)90142-N
  20. Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process of Cross-cultural adaptation of self-report measures. Spine. 2000, 25: 3186-3191. 10.1097/00007632-200012150-00014. 🔗 https://doi.org/10.1097/00007632-200012150-00014
  21. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P, ISPOR Task Force for Translation and Cultural Adaptation: Principles of good practice for the translation and cultural adaptation process for atient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for translation and cultural adaptation. Value Health. 2005, 8: 94-104. 10.1111/j.1524-4733.2005.04054.x. 🔗 https://doi.org/10.1111/j.1524-4733.2005.04054.x
  22. Streiner DL: A checklist for evaluating the usefulness of rating scales. Can J Psychiatry. 1993, 38: 140-148. 🔗 https://doi.org/10.1177/070674379303800214
  23. Streiner DL, Norman GR: Health measurement scales: A practical guide to their development and use. 2008, Oxford: University Press, 4 🔗 https://doi.org/10.1093/acprof:oso/9780199231881.001.0001
  24. Beaton DE, Smith P, Mahood Q, Hogg-Johnson S, van der Velde G, Steenstra I, Bombardier C: Course notes: measurement skills workshop. 2010, Toronto: University of Toronto Health Policy, Management and Evaluation
  25. Norman GR, Streiner DL, Biostatistics: The bare essentials. 2008, Hamilton: B.C. Decker Inc, 3
  26. Bodur H, Borman P, Ozdemir Y, Atan C, Kural G: Quality of life and life satisfaction in patients with Behcet's disease: relationship with disease activity. Clin Rheumatol. 2006, 25: 329-333. 10.1007/s10067-005-0046-8. 🔗 https://doi.org/10.1007/s10067-005-0046-8

Cite this article

Mohammed looti (2026). Arabic Behçet’s Disease Quality of Life Questionnaire. PSYCHOLOGICAL SCALES. Retrieved from https://scales.arabpsychology.com/s/arabic-behcets-disease-quality-of-life-questionnaire/

Mohammed looti. "Arabic Behçet’s Disease Quality of Life Questionnaire." PSYCHOLOGICAL SCALES, 14 Aug. 2026, https://scales.arabpsychology.com/s/arabic-behcets-disease-quality-of-life-questionnaire/.

Mohammed looti. "Arabic Behçet’s Disease Quality of Life Questionnaire." PSYCHOLOGICAL SCALES, 2026. https://scales.arabpsychology.com/s/arabic-behcets-disease-quality-of-life-questionnaire/.

Mohammed looti (2026) 'Arabic Behçet’s Disease Quality of Life Questionnaire', PSYCHOLOGICAL SCALES. Available at: https://scales.arabpsychology.com/s/arabic-behcets-disease-quality-of-life-questionnaire/.

[1] Mohammed looti, "Arabic Behçet’s Disease Quality of Life Questionnaire," PSYCHOLOGICAL SCALES, vol. X, no. Y, ص Z-Z, August, 2026.

Mohammed looti. Arabic Behçet’s Disease Quality of Life Questionnaire. PSYCHOLOGICAL SCALES. 2026;vol(issue):pages.

× Figure
PDF
Scroll to Top